Related Experiment Video
Updated: May 25, 2026
Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
IL4i1 activity generates oncometabolites that rescue neuroblastoma cells from oxidative death
Camille Guyot1, Lee-Ann Van de Velde2, Lisa Kainacher1
1Immunoregulation Research Group, Max Planck Institute of Biochemistry, Martinsried, Germany.
Abstract:
High-risk neuroblastoma (NB) is driven by the amplification of MYCN in conjunction with additional oncogenic mutations in genes encoding kinases such as ALK. NB cells require antioxidant responses to maintain redox balance and are highly sensitive to ferroptosis. Here, we show that metabolites derived from infiltrating immune cells expressing IL4i1, a secreted oxidoreductase, are potent suppressors of NB ferroptosis. IL4i1 metabolites (indole-3-pyruvate and 4-hydroxyphenylpyruvate) blocked ferroptosis in all human NB cell lines via a mechanism that depended on free radical scavenging and NRF2 activation but did not require the aryl hydrocarbon receptor. Supernatant transfer experiments confirmed that IL4i1 creates a milieu that protects NB cells from oxidative cell death. Importantly, mice lacking IL4i1 were protected from NB in a high-penetrance MYCN and mutant ALK-driven autochthonous cancer model. Therefore, we propose that immune IL4i1 is permissive for NB growth and survival. IL4i1 produces context-dependent oncometabolites and, as a secreted enzyme, represents a target for cell death manipulation in cancers sensitive to oxidative stress-driven cell death.
Insights
Immune cells expressing IL4i1 protect high-risk neuroblastoma (NB) from ferroptosis via metabolite production. Blocking IL4i1 in mice prevented NB growth, suggesting IL4i1 as a therapeutic target.
Area of Science:
- Immunology
- Oncology
- Metabolomics
Background:
- High-risk neuroblastoma (NB) is driven by MYCN amplification and oncogenic kinase mutations.
- NB cells rely on antioxidant defenses and are vulnerable to ferroptosis, a regulated cell death pathway.
- Immune cells infiltrating tumors can influence cancer progression.
Purpose of the Study:
- To investigate the role of immune cell-secreted IL4i1 in neuroblastoma ferroptosis and tumor growth.
- To identify the specific metabolites produced by IL4i1 and their mechanism of action.
- To evaluate IL4i1 as a potential therapeutic target for neuroblastoma.
Main Methods:
- In vitro studies using human NB cell lines and supernatant transfer experiments.
- Analysis of ferroptosis suppression mechanisms, including free radical scavenging and NRF2 activation.
- In vivo studies using a MYCN and mutant ALK-driven autochthonous mouse model lacking IL4i1.
Main Results:
- Metabolites from IL4i1-expressing immune cells suppressed ferroptosis in NB cell lines.
- IL4i1 metabolites (indole-3-pyruvate, 4-hydroxyphenylpyruvate) protected NB cells via free radical scavenging and NRF2 activation.
- Mice lacking IL4i1 showed protection against NB development in a relevant cancer model.
Conclusions:
- Immune-derived IL4i1 promotes NB growth and survival by suppressing ferroptosis.
- IL4i1 produces context-dependent oncometabolites that shield NB cells from oxidative stress.
- IL4i1 represents a promising target for therapeutic strategies aimed at inducing oxidative cell death in NB.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:23Abnormal Proliferation